ストックスクリーナーアプリを入手
2.06
3.97%
-0.08
前日終値:
$2.14
開ける：
$2.13
24時間の取引高:
86,792
Relative Volume:
0.66
時価総額：
$206.34M
収益：
-
当期純損益:
$-60.14M
株価収益率:
-2.9035
EPS:
-0.7095
ネットキャッシュフロー:
$-68.17M
1週間 パフォーマンス:
-6.38%
1か月 パフォーマンス:
+0.74%
6か月 パフォーマンス:
-19.09%
1年 パフォーマンス:
-37.35%
1日の値動き範囲:
$2.04
$2.13
1週間の範囲:
$2.04
$2.50
52週間の値動き範囲:
$1.4299
$3.98
Ac Immune Sa Stock (ACIU) Company Profile
ACIU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.055 | 218.30M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
375.71 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.11 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.63 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
636.80 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
287.78 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-31 | 開始されました | BTIG Research | Buy |
| 2019-02-01 | ダウングレード | UBS | Buy → Neutral |
| 2019-01-04 | 開始されました | UBS | Buy |
| 2018-04-05 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-23 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | 開始されました | Credit Suisse | Outperform |
| 2016-10-18 | 開始されました | Jefferies | Buy |
| 2016-10-18 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Ac Immune Sa (ACIU) 最新ニュース
Analyzing drawdowns of AC Immune SA with statistical toolsWeekly Stock Picks with Trend Confidence - Newser
How to use Fibonacci retracement on AC Immune SAHigh Reward Picks with Tight Risk Control - Newser
Using data models to predict AC Immune SA stock movementTechnical Setup and Return Forecast Engine - Newser
Ranking AC Immune SA among high performing stocks via toolsShort Term Profit Strategy with Entry Cues - Newser
Is AC Immune SA reversing from oversold territoryFree Capital Preserving Trade Plan Templates - Newser
What momentum shifts mean for AC Immune SAShort Squeeze Opportunities with Indicators - Newser
How to integrate AC Immune SA into portfolio analysis toolsDaily Breakout List with Smart Filters - Newser
Identifying reversal signals in AC Immune SALong-Term Stock Growth Forecast Insights - Newser
Backtesting results for AC Immune SA trading strategiesFree Community Entry Consensus Trade Ideas - Newser
Visual analytics tools that track AC Immune SA performanceShort-Term AI-Based Stock Price Forecast - Newser
Using AI based signals to follow AC Immune SAFree Short Term Buy Zone Stock Alerts - Newser
Can machine learning forecast AC Immune SA recoveryFree High Accuracy Alerts for ROI Traders - Newser
What makes AC Immune SA stock price move sharplyForecasting Stock Moves with AI Insights - Newser
Can AC Immune SA expand its profit marginsSmart Beta Portfolio Candidates - sisaissue.com
AC Immune SA: Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
Q3 Earnings Forecast for AC Immune Issued By Leerink Partnrs - Defense World
AC Immune Reports Q2 2025 Financial Progress - TipRanks
Visualizing AC Immune SA stock with heatmapsFree Weekly Growth Stock Entry Point Alerts - Newser
Chart based exit strategy for AC Immune SAImmediate Entry Point Prediction Strategy - Newser
Using R and stats models for AC Immune SA forecastingStock Market Watch with Smart Filters - Newser
Is AC Immune SA stock poised for growthWeekly Hot Stocks Based on Volume Flow - Newser
Will AC Immune SA stock split in the near futureFree Low Risk Swing Trade Opportunity List - Newser
New Strong Sell Stocks for August 6th - Yahoo Finance
AC Immune: Q2 Earnings Snapshot - New Haven Register
AC Immune reports Q2 EPS (CHF 0.21) vs. (CHF 0.23) last year - TipRanks
AC Immune SA reports results for the quarter ended June 30Earnings Summary - TradingView
AC Immune SA Reports Increased Losses in Mid-2025 Financial Results - TipRanks
AC Immune SA Reports Q2 2025 Financial Results and Advancements in Neurodegenerative Disease Therapies - Quiver Quantitative
Ac Immune Sa (ACIU) 財務データ
収益
当期純利益
現金流量
EPS
3.68%
0.41%
大文字化:
|
ボリューム (24 時間):